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Repair of chromosome breaks by non-homologous end
joining requires the XRCC4-ligase IV complex, Ku, and
the DNA-dependent protein kinase catalytic subunit
(DNA-PKcs). DNA-PKcs must also retain kinase activity
and undergo autophosphorylation at six closely linked
sites (ABCDE sites). We describe here an end-joining
assay using only purified components that reflects cel-
lular requirements for both Ku and kinase-active DNA-
PKcs and investigate the mechanistic basis for these
requirements. A need for DNA-PKcs autophosphoryla-
tion is sufficient to explain the requirement for kinase
activity, in part because autophosphorylation is gener-
ally required for end-joining factors to access DNA ends.
However, DNA-PKcs with all six ABCDE autophospho-
rylation sites mutated to alanine allows access to ends
through autophosphorylation of other sites, yet our in
vitro end-joining assay still reflects the defectiveness of
this mutant in cellular end joining. In contrast, muta-
tion of ABCDE sites to aspartate, a phosphorylation
mimic, supports high levels of end joining that is now
independent of kinase activity. This is likely because
DNA-PKcs with aspartate substitutions at ABCDE sites
allow access to DNA ends while retaining affinity for
Ku-bound ends and stabilizing recruitment of the
XRCC4-ligase IV complex. Autophosphorylation at AB-
CDE sites thus apparently directs a rearrangement of
the DNA-PK complex that ensures access to broken ends
and joining steps are coupled together within a synaptic
complex, making repair more accurate.
The mammalian non-homologous end-joining pathway has
an important role in all cell types for repair of double strand
breaks (DSBs)1 caused by DNA damage (e.g. after ionizing
radiation). End joining is also essential for efficient resolution
of DSB intermediates in V(D)J recombination, a lymphocyte-
specific process required for assembly of the antigen-specific
receptors of the immune system. Defective end joining thus
results in radiation sensitivity, an increased incidence of can-
cer, and severe immunodeficiency (1).
Repair of broken ends by this pathway requires 1) recogni-
tion of broken ends and recruitment of end-joining factors, 2)
alignment or synapsis of a pair of ends, and 3) processing by
polymerases or nucleases as needed to generate compatible
ends 4) followed by ligation. End joining uses the XRCC4-ligase
IV complex (LX) for the ligation step (2, 3), whereas the proc-
essing step uses at least the Artemis nuclease (4, 5) and
polymerase  (6, 7). The DNA-dependent protein kinase (DNA-
PK) has been linked to early steps in end joining, and consists
of the Ku heterodimer (Ku70 and Ku80) and a 460-kDa serine/
threonine DNA-PK catalytic subunit (DNA-PKcs). Ku is re-
quired for end recognition and, once loaded on ends, acts as a
scaffold for subsequent recruitment of DNA-PKcs (8), the LX
complex (9–11), polymerase  (6), and probably other factors as
well.
The role of DNA-PKcs is not well understood. Several obser-
vations, including its ability to associate with Artemis and
activate the endonuclease activity of Artemis (4), suggest a
specific role for DNA-PKcs in directing end-processing events;
however, DNA-PKcs deficiency affects cellular end joining even
when processing is not required (see Ref. 12 and references
therein). A more general role for DNA-PKcs in end joining is
also consistent with in vitro evidence indicating that it helps
Ku recruit the LX complex to ends (10, 13) and promotes the
intermolecular synapsis of two DNA ends (14). Together, these
functions of DNA-PKcs may explain why LX activity is neces-
sary in vitro when using substrates that do not require pro-
cessing (10, 15).
Recent studies indicate that cellular end joining requires
DNA-PKcs to undergo autophosphorylation (16–18). Six auto-
phosphorylation sites are clustered within a 40-amino acid
region (“ABCDE” sites) (see Fig. 2A), although at least two
other sites are also autophosphorylated (19). Individual muta-
tion of ABCDE sites has mild or negligible effects, but a mutant
with all six ABCDE sites converted to alanine (ABCDE(ala)) is
unable to complement DNA-PKcs-deficient cells (17). Auto-
phosphorylation in general had previously been shown in vitro
to trigger a dissociation of DNA-PKcs from Ku-bound ends (20,
21) and is required to make ends accessible to exogenous fac-
tors (e.g. exonucleases) (22, 23) and probably end-joining fac-
tors as well (24). Together, this evidence suggests that the
cellular defects of the ABCDE(ala) mutant could simply be
explained by its inability to be autophosphorylated and then
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dissociate, because its continued presence would prevent access
to DNA ends by other end-joining factors.
However, the purified ABCDE(ala) mutant protein also dis-
sociates after autophosphorylation (17). Autophosphorylation
of sites outside of the ABCDE cluster is therefore sufficient for
dissociation and end access, and the mechanism by which AB-
CDE autophosphorylation promotes end joining remains
unclear.
We therefore developed an in vitro assay using only purified
Ku, DNA-PKcs, and the LX complex that reflects the cellular
requirement for autophosphorylation at the ABCDE sites. We
show that autophosphorylation at ABCDE sites uniquely
makes ends accessible while still allowing DNA-PKcs to persist
at ends and retain LX within a complex at ends.
EXPERIMENTAL PROCEDURES
Proteins—Recombinant Ku heterodimer and LX were purified from
baculovirus-infected cells as described previously (9). DNA-PKcs was
purified from 50 g of human placenta (“native” DNA-PKcs) or 5 liters of
V3 cells stably expressing the various constructs (recombinant), also as
described previously (17), with the following exception. Instead of using
polyethyleneimine cellulose, nucleic acids were depleted by addition of
polyethyleneimine to the extract to 0.2% v/v, centrifugation at 15,000 
g for 15 min, and further clarification of the extract by the addition of
phosphocellulose to 10% v/v and filtration.
Approximate concentrations of proteins were calculated by Bradford
assay using bovine serum albumin as a standard, and quantitative
Western analyses, used to confirm these estimates, were accurate
within 20% when comparing different mutants.
When indicated, kinase activity of DNA-PKcs was blocked by prein-
cubation of a 100 nM protein stock with 10 M wortmannin (Sigma)
(dissolved in dimethyl sulfoxide) for 10 min on ice; thus, assays typically
contain less than 1 M wortmannin and 1% dimethyl sulfoxide. All
experiments compare activity of wortmannin-pretreated DNA-PKcs
with mock-treated DNA-PKcs (i.e. pretreated in the same way with the
appropriate amount of dimethyl sulfoxide).
Assays—All reactions contained 25 mM TRIS-HCl, pH 7.5, 50 g/ml
bovine serum albumin, 45 mM KCl, 105 mM NaCl, 0.05% Triton X-100,
0.1 mM EDTA, and 2 mM dithiothreitol.
End-joining assays used a 754-bp TaqI fragment of pUC18. Signifi-
cant LX activity with this substrate required Ku as long as LX concen-
tration was not in great excess over DNA ends. Additional requirement
for DNA-PKcs was observed when the concentration of Ku also did not
greatly exceed the concentration of DNA ends and when concentrations
of all components, including DNA ends, were reduced. Reactions were
supplemented with 10% polyethylene glycol (v/v) and, except as noted
for Fig. 1C, preincubated with Ku and DNA-PKcs for 10 min at 25 °C
before the addition of LX, 5 mM MgCl2, and 100 M ATP and transfer to
30 °C. Fig. 1C shows wortmannin (10 M final concentration) added to
reactions at the noted times during a 10-min preincubation, performed
with MgCl2 and ATP but without LX. Reactions shown in Fig. 1C were
then started by the addition of LX and transfer to 30 °C. All reactions
were stopped by the addition of an equal volume of a solution containing
25 mM TRIS-HCl, pH 8.0, 5 mM EDTA, 0.2% SDS, and 1 mg/ml pro-
teinase K, incubated at 55 °C for 1 h, and extracted with an equal
volume of phenol and chloroform, before electrophoresis on a 0.8%
agarose gel. Products were visualized by direct DNA staining with
SYBR green (Sigma) and by Southern analysis using the 5-32P-labeled
oligonucleotide YR11 (5-GCGTTTCGGTGATGACGGTGAAAAAC-
CTCTG-3) as a probe. The amount of product species was determined
using a PhosphorImager (Amersham Biosciences) and ImagequaNT
software.
The 60-bp double-stranded DNA substrate used in electrophoretic
mobility shift analysis assays has been described previously (9). Reac-
tions were assembled in standard buffer and incubated for 10 min at
room temperature before cross-linking with 0.06% glutaraldehyde. Fix-
ing with glutaraldehyde was not required for detection of DNA-protein
complexes, but this treatment reproducibly improved the definition of
retarded species. Complexes were resolved on a 3.5% polyacrylamide
gel in 90 mM TRIS borate, pH 8.2, and 1 mM EDTA (1 TBE) at 18
volts/cm.
For exonuclease assays, we used the 754-bp TaqI substrate described
above and 0.05 unit of exonuclease V (Amersham Biosciences). This
concentration was determined by serial dilution of enzyme to be the
minimum concentration of enzyme necessary to degrade 95% of the
full-length substrate in 5 min in the absence of other added proteins.
DNA-protein complexes were formed by preincubation at room temper-
ature for 5 min, after which exonuclease V, 5 mM MgCl2, and 500 M
ATP were added. Reactions were then incubated at 30 °C before being
stopped and deproteinized at the indicated times also as described for
ligation assays. Samples were subjected to electrophoresis on an 8%
polyacrylamide gel, and products were visualized with SYBR green
DNA stain (Sigma).
RESULTS
Requirement for Kinase-active DNA-PK in in Vitro End Join-
ing—We addressed the role of Ku and DNA-PKcs in in vitro
end joining by the LX complex using a 754-bp linear duplex
DNA substrate with 2-bp complementary overhangs. Both
DNA-PK subunits are required for significant LX activity when
using the conditions described here (Fig. 1A, compare lanes
2–5; see also “Experimental Procedures”). Importantly, end
joining is reduced more than 10-fold when the kinase activity of
DNA-PKcs is blocked by pretreatment with wortmannin (Fig.
1A, compare lanes 5 and 6).
We tested whether autophosphorylation of DNA-PK was suf-
ficient to explain the requirement for kinase activity by sepa-
rating the reaction into distinct autophosphorylation and liga-
tion stages (Fig. 1B). DNA-PK was autophosphorylated to
varying degrees in the first stage by addition of wortmannin at
the beginning (Fig. 1C, lane 2, 0 AutoP), after 2 min (Fig. 1C,
lane 3, 2 AutoP), or after 10 min (Fig. 1C, lane 5,10 AutoP) of
preincubation containing everything except LX. In the second
stage, LX was added to assess how well autophosphorylated
FIG. 1. Requirement for kinase-active DNA-PK in in vitro end
joining. A, the 754-bp substrate (S) and concatemer ligation products
(P) were detected by Southern analysis. All reactions contained 1.25 nM
substrate and, as indicated by , 1 nM LX, 2.5 nM Ku, and 5 nM
DNA-PKcs. Reactions were stopped 10 min after addition of LX. DNA-
PKcs was mock-treated () or wortmannin-treated to block kinase
activity prior to addition. B and C, reactions for Fig. 1C were performed
as in A, except with a 10-min preincubation at 25 °C in the absence of
LX, and end joining was assessed only 2 min after addition of LX.
Kinase activity (KIA) was blocked by wortmannin addition at the start
of preincubation (lane 2, 0 AutoP, KIA), or 2 min (lane 3, 2 AutoP, KIA)
and 10 min (lane 5, 10 AutoP, KIA) after the start of preincubation. In
lane 4, DNA-PKcs was mock-treated, and ATP and Mg2 were withheld
until addition of LX (kinase active). AutoP, autophosphorylation.
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DNA-PKcs promoted end joining but now without concurrent
kinase activity. As a standard for comparison, we allowed au-
tophosphorylation and ligation to proceed in parallel (essen-
tially as in Fig. 1A, lane 5) by omitting wortmannin and with-
holding ATP and Mg2 until the addition of LX (Fig. 1C, lane
4). Importantly, 2 min of autophosphorylation was sufficient to
make wild type DNA-PKcs independent of concurrent kinase
activity in the end-joining assay (Fig. 1C, compare lanes 3 and
4). Autophosphorylation of DNA-PK is thus sufficient to ex-
plain the role of kinase activity in this assay, and autophos-
phorylation need not occur in parallel with end joining to be
effective. More exhaustive autophosphorylation (10 min) still
promoted significant end-joining activity, but levels were re-
duced 2-fold relative to the 2-min autophosphorylation (Fig.
1C, compare lanes 3 and 5). Therefore, although at least some
autophosphorylation is required for end joining, the partial
autophosphorylation achieved after 2 min is most effective.
We next purified four DNA-PKcs variants with different
mutations at sites of autophosphorylation (Fig. 2, A and B) and
assessed their activity in this assay (Fig. 2C). Importantly,
ligation activity relative to wild type DNA-PKcs is reduced
10-fold when using a mutant in which autophosphorylation of
ABCDE serines and threonines is blocked by alanine substitu-
tions (ABCDE(ala)) (Fig. 2C, compare lanes 3 and 5). Similar
results were obtained with several independent preparations of
ABCDE(ala) and also after prolonged incubation (Fig. 2C, lanes
8–10). Previously, a phosphorylation site outside the ABCDE
cluster (serine 3205) was identified (19). Mutants of this site in
conjunction with ABCDE sites (ABCDEF(ala)) also behave sim-
ilarly to ABCDE(ala), both in cellular assays2 and in vitro (Fig.
2C, lane 6). In contrast, mutation of single sites in the ABCDE
cluster (A(ala), C(ala)) did not significantly reduce end joining
in vitro (Fig. 2, lane 7),3 consistent with the near wild type
ability of these mutants to promote radio resistance or V(D)J
recombination in cells (17). The requirements of this in vitro
end-joining assay for autophosphorylation within ABCDE are,
thus, identical to requirements previously revealed in cellular
end-joining assays (17).
Role of ABCDE Autophosphorylation—Levels of end joining
seen with the ABCDE(ala) mutant are similar to those seen
when kinase activity of wild type DNA-PKcs is blocked, indi-
cating that autophosphorylation of ABCDE sites is sufficient to
explain the role of kinase activity in this assay. However,
ABCDE(ala) is remarkably indistinguishable from wild type
DNA-PKcs in most other respects. This mutant retains wild
type levels of kinase activity as measured using p53 peptide,
Artemis (17), or Ku as targets.2 Electrophoretic mobility shift
2 K. Meek and Q. Ding, unpublished data. 3 Y. V. R. Reddy and D. A. Ramsden, unpublished data.
FIG. 3. DNA-PKcs protein-DNA complexes. A, reactions were in-
cubated for 10 min with 100 nM 32P-labeled 60-bp DNA duplex, 5 nM Ku,
5 mM MgCl2, and 200 M ATP, and autophosphorylation was controlled
by prior mock treatment (AutoP) or wortmannin treatment (AutoP)
of 10 nM DNA-PKcs. F, free DNA; I, Ku-bound DNA; II, Ku and DNA-
PKcs bound DNA. No complexes are observed without Ku. B, complexes
were formed as in A except without autophosphorylation (no preincu-
bation, MgCl2, or ATP). 10 nM LX and 10 nM various DNA-PKcs prep-
arations are included as noted, except lane 8 where 25 nM ABCDE(asp)
was added. Species III contained Ku, DNA-PKcs, and LX. A species
with mobility intermediate to II and III, containing Ku and LX but not
DNA-PKcs, was detected only at a reduced salt concentration (75 mM).
AutoP, autophosphorylation.
FIG. 2. In vitro end-joining activity of autophosphorylation
mutants. A, sites of autophosphorylated serine (S) and threonine (T) in
human DNA-PKcs (identified as in Ref. 17). B, Coomassie Blue-stained
SDS-PAGE of 1 g of purified DNA-PKcs proteins. Native wild type
DNA-PKcs (N) was purified from human placenta, whereas recombi-
nant wild type DNA-PKcs (R) and mutants were purified from DNA-
PKcs-deficient cell lines stably expressing appropriate constructs. C,
reactions were performed as in Fig. 1A and stopped 2 min (lanes 1–7) or
10 min (lanes 8–10) after addition of LX. All DNA-PKcs preparations
were wortmannin-treated to block kinase activity (KIA) or mock-treated
() prior to addition.
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analysis also indicates that ABCDE(ala) has wild type affinity
for Ku-bound DNA ends (17) (Fig. 3A, compare lanes 2 and 4),
and the ability of ABCDE(ala) to promote recruitment of LX to
DNA is equivalent to wild type DNA-PKcs (Fig. 3B, compare
lanes 3 and 5).
ABCDE(ala) does not dissociate as fully from Ku-bound ends
as does wild type DNA-PKcs after autophosphorylation, but it
does dissociate to some extent (17) (Fig. 3A, lanes 1–4). Auto-
phosphorylation of sites outside the ABCDE cluster is thus
largely sufficient for dissociation of DNA-PKcs.
We used the ABCDE(ala) mutant and an exonuclease pro-
tection assay to determine whether autophosphorylation of
sites outside the ABCDE cluster is sufficient to make DNA
ends accessible (Fig. 4). Ku and wild type DNA-PKcs are both
required to significantly delay digestion by exonuclease V.
Even when both factors are present, linear duplex DNA is well
protected only when the kinase is inactivated, consistent with
previous studies indicating that autophosphorylation is re-
quired for exonucleases to access DNA ends (22, 23) (Fig. 4,
compare solid with dashed lines). Importantly, the ABC-
DE(ala) mutant is indistinguishable from wild type DNA-PKcs
in this assay as well, because autophosphorylation of either
protein leads to the parallel progressive digestion of substrate
by exonuclease V (Fig. 4, compare squares with triangles). Wild
type DNA-PKcs and ABCDE(ala) thus both allow access to
ends on autophosphorylation, but only wild type DNA-PKcs
supports high levels of joining by the LX complex. We conclude
that simply providing access to ends does not explain why
autophosphorylation at ABCDE sites is so critical for cellular
end joining.
We suggest instead that ABCDE autophosphorylation may
be essential for end-joining activity because it might confer end
accessibility, while still allowing DNA-PKcs to remain associ-
ated. Persistence of DNA-PKcs at ends would allow it to con-
tinue promoting synapsis of ends and stabilizing recruitment of
LX, thus enabling LX to take advantage of end synapsis. This
hypothesis predicts that DNA-PKcs autophosphorylated only
within ABCDE sites should allow access to ends but retain the
ability to form a complex with end-joining factors. To test these
predictions, we modeled a DNA-PKcs molecule in which auto-
phosphorylation is restricted to ABCDE sites by using a mu-
tant with aspartates (a phosphorylation mimic) substituted at
ABCDE sites instead of alanines.
In the presence of ABCDE(asp), ends are sensitive to exonu-
clease digestion even when kinase activity is blocked by wort-
mannin (Fig. 4), suggesting that autophosphorylation re-
stricted to ABCDE is sufficient for end access. ABCDE(asp)
nevertheless still forms a complex with Ku at DNA ends, al-
though roughly one-third as well as wild type DNA-PKcs (Fig.
3A, compare lanes 4 and 6). ABCDE(asp) retains kinase activ-
ity (17), and autophosphorylation of this mutant at sites out-
side the ABCDE cluster is required for complete dissociation
(Fig. 3A, compare lanes 5 and 6), as argued previously (17) from
the study of the ABCDE(ala) mutant. More significantly, AB-
CDE(asp) still promotes recruitment of the LX complex (Fig.
3B, compare lane 1 with lanes 7 and 8). DNA-PKcs autophos-
phorylated only within ABCDE thus permits access to ends,
maintains affinity for Ku-bound ends, and helps retain LX at
ends.
We have shown that at least partial autophosphorylation of
DNA-PKcs within ABCDE sites is essential for end-joining
activity (Figs. 1 and 2), but the experiments described above
suggest it may also be sufficient (i.e. autophosphorylation out-
side ABCDE may be dispensable for end-joining activity in this
context). We addressed this possibility by assessing whether
ABCDE(asp) was active in the end-joining assay, even when
kinase activity was blocked by wortmannin treatment. ABC-
DE(asp) was only 2-fold less effective than wild type DNA-PKcs
in promoting end joining, in contrast to ABCDE(ala) (Fig. 5,
compare lanes 2 and 4). More importantly, the ability of wild
type DNA-PKcs to support end joining requires kinase activity,
but ABCDE(asp) does not (Fig. 5, compare lanes 4 and 5). This
argues that autophosphorylation within ABCDE is both neces-
sary and sufficient for activity of LX in vitro.
DISCUSSION
We have developed an in vitro end-joining assay using only
purified Ku, DNA-PKcs, and LX. These are the factors required
for non-homologous end joining in cells, so that our assay
reflects the cellular end-joining process. Furthermore, our sys-
tem depends on the ability of DNA-PKcs to undergo autophos-
phorylation at ABCDE sites in exact parallel to the situation in
vivo. Our results using this assay indicate that ABCDE auto-
phosphorylation leads to a destabilization of DNA-PK that is
critical for significant end-joining activity. By comparison, au-
tophosphorylation outside the ABCDE cluster has a similar
impact on DNA-PK complex stability but does not support end
joining. We therefore propose that autophosphorylation within
ABCDE is uniquely able to direct a rearrangement of the
DNA-PK complex at DNA ends that is essential for end joining
both in vitro and in cells. This requirement offers important
advantages to the end joining repair pathway because it en-
FIG. 4. Accessibility of DNA ends. End accessibility was deter-
mined by assessing the fraction of full-length substrate remaining over
time after the addition of 0.05 unit of exonuclease V to reactions con-
taining 1.25 nM 754-bp substrate, 5 nM Ku, and 10 nM of various
DNA-PKcs preparations (squares, wild type; triangles, ABCDE(ala);
circles, ABCDE(asp)). DNA-PKcs preparations were mock-treated
(solid lines, kinase active) or wortmannin-treated to block kinase activ-
ity (dashed lines, kinase inactive) prior to addition.
FIG. 5. Effect of autophosphorylation on end joining. Reactions
were assembled as in Fig. 1A. DNA-PKcs was mock-treated (Kinase )
or inactivated by wortmannin pretreatment (Kinase ). S, substrate; P,
concatemer ligation products.
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sures the seamless coupling of each step in end joining to the
next as described below (Fig. 6).
Ku and DNA-PKcs initially recruit LX and other end-joining
factors to DNA ends, but ends remain inaccessible even to
factors within this complex when autophosphorylation is
blocked (Fig. 1A) (22–24). Autophosphorylation (and kinase
activity in general) is stimulated when ends are brought to-
gether (synapsis) (Fig. 6, step 2) (14, 22). Autophosphorylation
thus links end accessibility to synapsis, helping to ensure that
only enzymes specific to this pathway, and thus already pres-
ent within the synaptic complex, can act on ends. The ABC-
DE(asp) mutant uncouples accessibility from synapsis. This
“partially autophosphorylated” DNA-PKcs has only intermedi-
ate levels of end joining relative to wild type and the ABC-
DE(ala) mutant, both in vitro and in cellular assays (17). How-
ever, reduced effectiveness of the ABCDE(asp) mutant is
particularly evident in cells, probably reflective of the greater
risk posed by indiscriminate end accessibility in a cellular
environment.
Once the kinase is activated, autophosphorylation occurs
both within the ABCDE cluster and at other sites that are
currently being characterized. Our data indicate that ABCDE
and other sites are autophosphorylated independently, and
either set of autophosphorylations alone is sufficient to make
ends accessible (Fig. 4). Therefore, we argue that the primary
problem with cells expressing the ABCDE(ala) mutant is not
that this mutant blocks the ability of processing factors to
access ends. In support of this argument, hairpin intermediates
in V(D)J recombination are opened (processed) with similar
efficiency in cells expressing either wild type DNA-PKcs or the
ABCDE(ala) mutant, but these processed intermediates are not
joined in cells expressing ABCDE(ala) (17). Moreover, the AB-
CDE(ala) mutant is also unable to promote wild type levels of
signal end joining in cells, a reaction that does not require
processing (17). The primary problem with end joining in cells
expressing ABCDE(ala) must therefore be that they are unable
to couple synapsis with end access and LX activity (and prob-
ably the activity of other end-joining factors as well). This is
presumably because ABCDE autophosphorylation of DNA-
PKcs is uniquely able to combine end accessibility with its
retention at ends (Fig. 6, step 3). Although bound to ends in this
manner, DNA-PKcs can continue fulfilling its role in promoting
end synapsis and the stable recruitment of LX until repair is
complete.
Autophosphorylation restricted to either ABCDE sites or
outside sites has an equivalent impact on how well DNA-PKcs
interacts with Ku-bound DNA ends (Fig. 3A, compare lane 2
with lanes 3 and 6). However, our data suggest that autophos-
phorylation within ABCDE allows access to ends prior to DNA-
PKcs dissociation, whereas autophosphorylation of outside
sites permits access only when a sufficient number of sites have
been phosphorylated so that DNA-PKcs dissociates. This sug-
gests a clear mechanistic difference in how the two types of
autophosphorylation affect DNA interactions. It is likely that
ABCDE autophosphorylation alters the DNA-PK complex by
limiting its impact on the DNA binding activity of DNA-PKcs to
the specific disruption of interactions involved in end protec-
tion (Fig. 6, step 3). In contrast, autophosphorylation at sites
outside the ABCDE cluster might disrupt an alternate DNA-
binding site not involved in end protection or indirectly impact
DNA binding by disrupting interactions with Ku. Consistent
with the former idea, biochemistry and electron microscopy
support a two-site model for DNA-PKcs interaction with DNA,
in which one site interacts with DNA ends, whereas the other
independently interacts with the DNA backbone, 15–20 bp
removed from the end (25).
Continued autophosphorylation of DNA-PKcs leads to a pro-
gressive reduction in DNA-binding activity and eventually
complete dissociation (Fig. 6, step 4) (20, 21). This may be
required for processing events that require a greater degree of
access to ends than does ligation. More likely, because DNA-
PKcs has a role in stabilizing recruitment of LX (Fig. 3B) (10,
13), Artemis (4), and likely other factors as well, dissociation of
DNA-PKcs may trigger the general disassembly of the entire
end-joining complex, with the possible exception of Ku. Disas-
sembly of the end-joining complex could be important in mak-
ing the successfully repaired junction accessible for subsequent
transactions (e.g. transcription and replication). Alternatively,
the eventual disassembly of end-joining factors from breaks
when repair fails may help cells by making these breaks acces-
sible to other repair pathways. The latter argument is sug-
gested by the ability of a specific inhibitor of DNA-PKcs kinase
activity to disrupt homologous recombination-dependent repair
of DSBs (26).
DSBs can still be repaired by end joining in the absence of
DNA-PK (Ku and DNA-PKcs), but this “backup” pathway is
less accurate (27–29) and more prone to cancer-causing trans-
locations (30) than when DNA-PK is present. We suggest that
a major reason for this is the ability of ABCDE autophospho-
rylation to ensure that once ends have been recognized by
DNA-PK only the factors appropriate to this pathway, and thus
present with DNA-PK in the synaptic complex, can be em-
ployed productively. On the other hand, processing events that
are not coupled to synapsis will be blocked, explaining how
DNA-PK makes end joining more accurate.
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